Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Payables (2016 - 2025)

Historic Payables for Rockwell Medical (RMTI) over the last 17 years, with Q3 2025 value amounting to $2.0 million.

  • Rockwell Medical's Payables fell 3546.81% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 million, marking a year-over-year decrease of 3546.81%. This contributed to the annual value of $3.1 million for FY2024, which is 3409.66% down from last year.
  • According to the latest figures from Q3 2025, Rockwell Medical's Payables is $2.0 million, which was down 3546.81% from $2.2 million recorded in Q2 2025.
  • Rockwell Medical's Payables' 5-year high stood at $6.7 million during Q2 2023, with a 5-year trough of $2.0 million in Q3 2025.
  • For the 5-year period, Rockwell Medical's Payables averaged around $4.1 million, with its median value being $4.2 million (2022).
  • Per our database at Business Quant, Rockwell Medical's Payables skyrocketed by 4962.93% in 2023 and then crashed by 5950.4% in 2025.
  • Quarter analysis of 5 years shows Rockwell Medical's Payables stood at $4.2 million in 2021, then grew by 9.1% to $4.6 million in 2022, then grew by 4.48% to $4.8 million in 2023, then plummeted by 34.1% to $3.1 million in 2024, then crashed by 36.72% to $2.0 million in 2025.
  • Its Payables was $2.0 million in Q3 2025, compared to $2.2 million in Q2 2025 and $2.0 million in Q1 2025.